Professor Liviu Movileanu is the recipient of two grant awards from the National Institutes of Health. One is a four-year, renewal Research Project Grant (R01) for $1.2 million, supporting ongoing development of nanopore-based biosensors, used to study transient protein-protein interactions (PPIs) in cell signaling under tumor-like conditions. The other grant is a $58,000 instrumentation supplement, associated with a second, parallel R01 award, funding the purchase of a single-molecule, electrical recording device for studying PPIs with colleagues at SUNY Upstate Medical University. “These proposed studies will impact healthcare by creating selective nanodevices that operate in complex biological fluids and in a high-throughput fashion,” he says.